{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:25:35Z","timestamp":1790249135961,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-MH105488"],"award-info":[{"award-number":["R01-MH105488"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.neuropharm.2017.04.018","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T13:49:59Z","timestamp":1492177799000},"page":"84-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Mechanisms contributing to cognitive deficits in cannabis users"],"prefix":"10.1016","volume":"124","author":[{"given":"Romina","family":"Mizrahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-5409","authenticated-orcid":false,"given":"Jeremy J.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei Y.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.04.018_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2008.12.002","article-title":"Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use","volume":"43","author":"Ashtari","year":"2009","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib2","doi-asserted-by":"crossref","first-page":"e55821","DOI":"10.1371\/journal.pone.0055821","article-title":"Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings","volume":"8","author":"Batalla","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib3","article-title":"Attenuated frontal and sensory inputs to the basal ganglia in cannabis users","author":"Blanco-Hinojo","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopsych.2012.01.008","article-title":"Effects of delta9-tetrahydrocannabinol on human working memory function","volume":"71","author":"Bossong","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pnpbp.2013.11.017","article-title":"Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or 9-tetrahydrocannabinol (THC)","volume":"52","author":"Bossong","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","article-title":"Acute and chronic effects of cannabinoids on human cognition-a systematic review","volume":"79","author":"Broyd","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fphar.2012.00101","article-title":"Association of cannabis use during adolescence, prefrontal CB1 receptor signaling, and schizophrenia","volume":"3","author":"Caballero","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00019052-200008000-00008","article-title":"Neural bases of learning and memory: functional neuroimaging evidence","volume":"13","author":"Cabeza","year":"2000","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/brain\/awl064","article-title":"Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation","volume":"129","author":"Chang","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.biopsych.2011.10.029","article-title":"Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study","volume":"71","author":"Cheetham","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2016.03.010","article-title":"Effect of cannabis on glutamate signalling in the brain: a systematic review of human and animal evidence","volume":"64","author":"Colizzi","year":"2016","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11065-012-9222-1","article-title":"Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences","volume":"23","author":"Crane","year":"2013","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","article-title":"Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users","volume":"164","author":"Curran","year":"2002","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"Curran","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib16","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bpsc.2015.09.008","article-title":"Rapid changes in CB1 receptor availability in cannabis dependent males after abstinence from cannabis","volume":"1","author":"D'Souza","year":"2016","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0269881115615104","article-title":"The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: a placebo-controlled, double-blind, crossover pilot trial","volume":"30","author":"Englund","year":"2016","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","article-title":"Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Delta(9)-THC: mechanism underlying greater toxicity?","volume":"97","author":"Fantegrossi","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drugalcdep.2014.04.002","article-title":"Differential reward network functional connectivity in cannabis dependent and non-dependent users","volume":"140","author":"Filbey","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib22","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1523\/JNEUROSCI.17-05-01880.1997","article-title":"Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay","volume":"17","author":"Floresco","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbr.2008.12.001","article-title":"Neural circuits subserving behavioral flexibility and their relevance to schizophrenia","volume":"204","author":"Floresco","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"issue":"754","key":"10.1016\/j.neuropharm.2017.04.018_bib26","first-page":"e751","article-title":"The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers","volume":"151","author":"Gorelick","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0269881111400649","article-title":"Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing","volume":"26","author":"Horder","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","article-title":"Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716","volume":"58","author":"Huestis","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib30","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.2174\/13816128113199990426","article-title":"Effects of cannabis on the adolescent brain","volume":"20","author":"Jacobus","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00213-005-0298-7","article-title":"Long-term effects of frequent cannabis use on working memory and attention: an fMRI study","volume":"185","author":"Jager","year":"2006","journal-title":"Psychopharmacol. Berl."},{"issue":"561\u2013572","key":"10.1016\/j.neuropharm.2017.04.018_bib32","first-page":"e561","article-title":"Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study","volume":"49","author":"Jager","year":"2010","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib33","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s00213-016-4398-3","article-title":"An MRI study of white matter tract integrity in regular cannabis users: effects of cannabis use and age","volume":"233","author":"Jakabek","year":"2016","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-004-1885-8","article-title":"Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study","volume":"176","author":"Kanayama","year":"2004","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2125.2012.04164.x","article-title":"Novel Delta(9) -tetrahydrocannabinol formulation Namisol(R) has beneficial pharmacokinetics and promising pharmacodynamic effects","volume":"74","author":"Klumpers","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib36","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/npp.2014.160","article-title":"Dopamine modulation of GABAergic function enables network stability and input selectivity for sustaining working memory in a computational model of the prefrontal cortex","volume":"39","author":"Lew","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/bjp.bp.114.151407","article-title":"Gross morphological brain changes with chronic, heavy cannabis use","volume":"206","author":"Lorenzetti","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib38","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.biopsych.2015.11.013","article-title":"The role of cannabinoids in neuroanatomic alterations in cannabis users","volume":"79","author":"Lorenzetti","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s002130050733","article-title":"The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide","volume":"140","author":"Mallet","year":"1998","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0920-9964(02)00294-3","article-title":"Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings","volume":"60","author":"Manoach","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and Delta(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib42","doi-asserted-by":"crossref","first-page":"E2657","DOI":"10.1073\/pnas.1206820109","article-title":"Persistent cannabis users show neuropsychological decline from childhood to midlife","volume":"109","author":"Meier","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib43","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/026988110401800407","article-title":"Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats","volume":"18","author":"O'Shea","year":"2004","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archpsyc.58.10.909","article-title":"Neuropsychological performance in long-term cannabis users","volume":"58","author":"Pope","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacol. Berl."},{"issue":"12","key":"10.1016\/j.neuropharm.2017.04.018_bib47","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1038\/npp.2013.164","article-title":"Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice","volume":"38","author":"Raver","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuropharm.2014.07.006","article-title":"Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms","volume":"86","author":"Raver","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuron.2009.06.021","article-title":"Activity-dependent regulation of synapses by retrograde messengers","volume":"63","author":"Regehr","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-012-2865-z","article-title":"Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison","volume":"225","author":"Renard","year":"2013","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib51","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1300225","article-title":"Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats","volume":"28","author":"Schneider","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1369-1600.2008.00117.x","article-title":"Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats","volume":"13","author":"Schneider","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291715001646","article-title":"The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis","volume":"46","author":"Schoeler","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib54","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/a0029117","article-title":"Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis","volume":"20","author":"Schreiner","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1874473710801010099","article-title":"The influence of marijuana use on neurocognitive functioning in adolescents","volume":"1","author":"Schweinsburg","year":"2008","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib56","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","article-title":"Cognitive functioning of long-term heavy cannabis users seeking treatment","volume":"287","author":"Solowij","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2017.04.018_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874473710801010081","article-title":"The chronic effects of cannabis on memory in humans: a review","volume":"1","author":"Solowij","year":"2008","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1471-4159.1993.tb03576.x","article-title":"Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase","volume":"61","author":"Vogel","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2015.05.046","article-title":"Cannabis, cigarettes, and their co-occurring use: disentangling differences in default mode network functional connectivity","volume":"153","author":"Wetherill","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2017.04.018_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0269881108096509","article-title":"Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625","volume":"24","author":"Zuurman","year":"2010","journal-title":"J.\u00a0Psychopharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:28:33Z","timestamp":1750199313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817301685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":61,"alternative-id":["S0028390817301685"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms contributing to cognitive deficits in cannabis users","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}